As injuries from the abortion pill mifepristone force women into emergency rooms across the nation, House Democrats recently attempted to block a federal investigation into the drug's alarming side effects. This move showcases a stunning hypocrisy as they have spent the last year attacking Republicans for questioning the safety of this very medication.
FDA Investigation Receives Congressional Support
On Monday night, the House Appropriations Committee included a statement in the markup of the Fiscal Year 2026 Agriculture Appropriations Bill that supports the FDA's review of mifepristone. The report explicitly states, "The [c]ommittee supports the FDA conducting an internal review in light of new findings and data." They are demanding a briefing from the FDA within 30 days of the review's completion, which highlights the seriousness of the situation.
Democratic Attempts to Obstruct Safety Review
Rep. Lauren Underwood (D-Ill.) proposed an amendment to remove this crucial language, prompting Republicans to highlight mifepristone's deadly history. Rep. Riley Moore (R-W.Va.) stated that Democrats are prioritizing abortion on demand over the safety and health of women. This amendment, as Rep. Robert Aderholt (R-Ala.) noted, would prevent the FDA from taking necessary steps to safeguard women's health.
Rep. Lauren Underwood DNC speech from Democratic convention ...
Political Motivations Behind Democratic Actions
Rep. Andy Harris (R-Md.) criticized Underwood's amendment, asserting it sets a dangerous precedent by preventing FDA surveillance on mifepristone. His concerns echo broader fears that Democrats are motivated by political agendas rather than genuine concern for women's health. Harris pointed out that many studies supporting mifepristone have ties to institutions that profit from abortion, raising questions about their credibility.
Testimonies Reveal Harrowing Experiences
Survivors of mifepristone's use have shared harrowing accounts of their experiences. One woman, using the name "Patricia," recounted, "I was bleeding so heavily, I believed I was dying. I was passing clots the size of baseballs, and I was in the worst physical pain of my life, worse than childbirth." Such testimonies expose the emotional and physical trauma many women endure following chemical abortions.
Washington.DC Nationwide News
Serious Risks Associated with Mifepristone
Reports indicate that mifepristone has been linked to severe complications, including sepsis, infection, and hemorrhage. Between 2000 and 2021, the FDA documented over 4,200 adverse events related to mifepristone, including 26 deaths. Rep. Andy Clyde (R-Ga.) emphasized the lack of accountability when mifepristone pills cross state lines, often arriving anonymously and without proper identification. This lack of oversight raises significant concerns about the safety protocols surrounding this controversial drug.
Democrats' Disturbing Track Record
Despite the alarming data, Democrats have historically dismissed concerns about mifepristone's safety. They often cite pro-life laws in tragic cases like that of Amber Nicole Thurman, yet ignore similar tragedies occurring in permissive states. For instance, Alyona Dixon, a 24-year-old woman, died of sepsis after a chemical abortion in Nevada. Such incidents illustrate the dire need for thorough investigations into the safety of chemical abortions.
These highlights do not include all the information needed to ...
Public Demand for Accountability
Mary Szoch, director of the Center for Human Dignity at the Family Research Council, posed a critical question: "What are Democrats afraid of?" The American public deserves transparency and accountability regarding the risks of mifepristone. It is vital that the FDA is allowed to conduct an unbiased review to ensure the safety of women and their unborn children.
